FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novel Laboratories Famotidine for Oral Suspension Recall

Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, N…

Novel Laboratories, Inc. · Somerset, NJ

Risk level
Class III
Reported by FDA
Sep 3, 2014
Recall ID
D-1484-2014
Check your lot numberHow we source this data

Summary

Novel Laboratories recalled Famotidine for Oral Suspension starting Jun 20, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1484-2014 on Sep 3, 2014. Reason: Failed Impurity/Degradation Specification; 12-month stability time point. Status: Terminated.

Why it was recalled

Failed Impurity/Degradation Specification; 12-month stability time point

Product description

Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.

Lot numbers, UPCs & expiration codes

Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1484-2014
Classification
Class III
Status
Terminated
Recall initiated
Jun 20, 2014
FDA report date
Sep 3, 2014
Quantity
25,776 containers
Recall type
Voluntary: Firm initiated
Recalling firm
Novel Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1484-2014, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
68722
Address
400 Campus Dr
Code information
Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016.
Postal code
08873-1145
Report date
Sep 3, 2014
Product type
Drugs
Recall number
D-1484-2014
Classification
Class III
Recalling firm
Novel Laboratories, Inc.
Product quantity
25,776 containers
Termination date
Jun 29, 2015
Reason for recall
Failed Impurity/Degradation Specification; 12-month stability time point
Voluntary / mandated
Voluntary: Firm initiated
Product description
Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.
Distribution pattern
Nationwide
Recall initiation date
Jun 20, 2014
Initial firm notification
Letter
Center classification date
Aug 22, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1484-2014, published Sep 3, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls